🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In asthmatics with airway hyperresponsiveness and a "T2 immune signature" (...
Status
Completed
Location
Firestone Institute for Respiratory Health, St. Joseph's Healthcare
Start Date
2019-07-01
Trial ID
NCT03884842
Treatments Being Tested
24-week, open-label, single-arm longitudinal study of patients with AD, inc...
Status
Unknown
Location
Multiple Locations
Start Date
2020-09-01
Trial ID
NCT04520308
Treatments Being Tested
The investigators believe that administering Dupilumab during the pre- and ...
Status
Completed
Location
Centre Hospitalier de l'Université de Montréal (CHUM)
Start Date
2021-05-25
Trial ID
NCT04596189
Treatments Being Tested
The goal of this clinical trial is to learn if dupilumab works to treat sev...
Status
Recruiting
Location
National University Hospital
Start Date
2025-11-27
Trial ID
NCT07091175
Often when people with asthma get a virus caused by the common cold (rhinov...
Status
Recruiting
Location
University of Virginia
Start Date
2022-05-01
Trial ID
NCT04380038
Treatments Being Tested
This is a randomised, double-blind, three-arm, parallel group, single-dose,...
Status
Recruiting
Location
Parexel EPCU Berlin
Start Date
2026-02-09
Trial ID
NCT07358156
Treatments Being Tested
This is a parallel group, treatment, Phase 1, open-label, 2-arm study to de...
Status
Completed
Location
Clinical Pharmacology of Miami-Site Number:8400001
Start Date
2021-06-08
Trial ID
NCT05976386
Treatments Being Tested
The goal of this observational study is to comprehensively profile six immu...
Status
Recruiting
Location
Radboud University Medical Center
Start Date
2025-07-29
Trial ID
NCT07021495
This is a phase 1, single subcutaneous dose study to evaluate safety and ph...
Status
Completed
Location
Prism Research-Site Number:840001
Start Date
2015-01-05
Trial ID
NCT05976373
Treatments Being Tested
Primary Objective: To evaluate the effect of dupilumab, compared to placeb...
Status
Completed
Location
Investigational Site Number 840402
Start Date
2016-01-27
Trial ID
NCT02573233